Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review ...

The U.S. Food and Drug Administration (FDA) has been looking into regulating CBD since official committees began gathering in May 2019. The government entity is now placing a laser focus on the ...

While several firms are exploring using genetically engineered yeast to biosynthesize cannabinoids using a fermentation process (rather than extracting them from cannabis plants), German company ...

Speaking at a Brookings Institution event on Tuesday, FDA Commissioner Scott Gottlieb shared some updates regarding the status of hemp-derived CBD at the national level. Gottlieb said he recognizes ...

CBD products have been popping up everywhere, both online and in retailers. The differentiating factor typically comes down to production - and bioMD+ has discovered a patented process of CO2 ...